Published in

Royal Society of Chemistry, Nanoscale, 5(16), p. 2347-2360, 2024

DOI: 10.1039/d3nr04777f

Links

Tools

Export citation

Search in Google Scholar

AGuIX nanoparticle-nanobody bioconjugates to target immune checkpoint receptors

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Comparison of click chemistry and sortagging grafting strategies for functionalizing AGuIX nanoparticles with nanobodies to develop a tri-functional technology combining MRI imaging, radiotherapy, and immunotherapy by inhibiting immune checkpoints.